Filed in archive
Corporate and Industrial News
, Drugs, Vaccines and Therapeutics
by ruth on April 22, 2006
"This pivotal trial for Bronchitol is the final step before registration in Australia, New Zealand and the European Union.
When complete, the results of the study should provide sufficient data for a marketing application to be lodged."
Bronchitol is a is medication being developed not only for the treatment of chronic obstructive pulmonary disease such as bronchoectasis and chronic bronchitis, but also against cystic fibrosis. The drug is produced from mannitol, a naturally occuring sugar, and comes as inhalable dry powder that can be administered via a hand-held, pocket-sized device.
[Photo: Medline Plus]
Permalink: Bronchitol, Under Phase 3 Clinical Trials
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/20506
Addthis
Ask
Blinklist
del.icio.us
Digg
Fark
Facebook
Google
Lycos
Ma.gnolia
Mr Wong
Netscape
Netvousz
Newsvine
Reddit
StumbleUpon
Slashdot
Tailrank
Technorati
Wink
Yahoo
Vote for Bronchitol, Under Phase 3 Clinical Trials:
|
Rating: 8.83 out of 6 vote(s) cast.
|
Response from:
Rita
(06/28/07 10:10am)
Good news!
Response from:
erin
(05/23/08 1:42am)
does this help with asbestosis related bronchiectasis .???
Response from:
Robert
(05/26/08 9:48am)
This is the best product I have used for my bronchiectasis
Response from:
Oyebode Olatade
(08/07/08 11:53am)
'Am a Nigerian suffering from Brochiectasis. Is it possible to have access to such drug. 'll be grateful to recieve a response from you. Bode
Subscribe
Use the search to look for other interesting posts
| RSS |  See all blog subscribe options |
 What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |
